Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Kidney Int. 2017 Mar 17;92(1):238–247. doi: 10.1016/j.kint.2017.01.024

Table 3.

Association analysis of sarcopenia and death

Methods Unadjusted Model 1 Model 2 Model 3




HR (95%CI) p HR (95%CI) p HR (95%CI) p HR (95%CI) p
Low muscle mass by each criteria and low grip strength

 Low muscle mass by Height2 4.23 (2.11–8.49) 0.001 2.61 (1.18–5.73) 0.02 2.83 (1.27–6.33) 0.01 2.23 (0.99–5.00) 0.05
 + weakness C = 0.55 C = 0.64 C = 0.65 C = 0.73
 Low muscle mass by BW 2.51 (1.46–4.31) 0.001 1.60 (0.82–3.10) 0.17 1.59 (0.82–3.07) 0.17 1.24 (0.63–2.43) 0.54
 + weakness C = 0.56 C = 0.63 C = 0.64 C = 0.72
 Low muscle mass by BSA 2.58 (1.58–4.20) 0.001 1.77 (0.97–3.22) 0.06 1.83 (1.00–3.33) 0.05 1.53 (0.84–2.78) 0.16
 + weakness C = 0.58 C = 0.64 C = 0.65 C = 0.73
 Low muscle mass by BMI 2.46 (1.48–4.09) 0.001 1.69 (0.91–3.14) 0.10 1.72 (0.92–3.20) 0.09 1.65 (0.88–3.08) 0.12
 + weakness C = 0.56 C = 0.62 C = 0.64 C = 0.72

Low muscle mass by each criteria and slow gait speed

 Low muscle mass by Height2 4.86 (2.42–9.76) 0.001 3.23 (1.52–6.85) 0.002 3.31 (1.54–7.12) 0.002 2.92 (1.33–6.41) 0.01
 + slowness C = 0.56 C = 0.64 C = 0.65 C = 0.73
 Low muscle mass by BW 2.67 (1.61–4.40) 0.001 1.94 (1.09–3.45) 0.03 1.85 (1.03–3.31) 0.04 1.56 (0.85–2.83) 0.15
 + slowness C = 0.57 C = 0.64 C = 0.64 C = 0.72
 Low muscle mass by BSA 2.63 (1.59–4.33) 0.001 1.84 (1.04–3.27) 0.04 1.79 (1.01–3.17) 0.04 1.46 (0.83–2.58) 0.19
 + slowness C = 0.58 C = 0.64 C = 0.64 C = 0.73
 Low muscle mass by BMI 3.35 (2.05–5.45) 0.001 2.62 (1.48–4.66) 0.001 2.55 (1.43–4.54) 0.002 2.51 (1.41–4.66) 0.002
 + slowness C = 0.58 C = 0.64 C = 0.64 C = 0.73

BW, body weight; BMI, body mass index; BSA, body surface area; C, C-statistic; HR, hazard ratio; 95% CI, 95% confidence interval.

Model 1: Adjusted for age, sex, and race; Model 2: Adjusted for age, sex, race, and comorbidities (diabetes mellitus, congestive heart failure, coronary artery disease); Model 3: Further adjusted for serum albumin.